NUDT15 Genetic Polymorphism as a Risk Factor for Early Neutropenia During Valganciclovir Prophylaxis in Lung Transplant Patients

Documenti analoghi

• Valganciclovir and Risk for Neutropenia: When the Friend Becomes the Foe
  di: Nadya Nalli, et al.
  Pubblicazione: (2024)
• A Rapid Colorimetric Method for Determining Calcium, Inorganic Phosphorus, and Zinc in Human Milk Using Clinical Laboratory Reagents
  di: Miori Tanaka, et al.
  Pubblicazione: (2025)
• A Matched Case‐Control Study to Evaluate Predicted Drug Exposures and Neutropenia during Valganciclovir Prophylaxis in Pediatric Solid Organ Transplant Recipients
  di: Mai‐Uyen T. Nguyen, et al.
  Pubblicazione: (2025)
• Correspondence On: “Valganciclovir Underdosing Is Associated With Cytomegalovirus DNAemia During Universal Prophylaxis”
  di: Pınar Belviranlı Keskin, et al.
  Pubblicazione: (2026)
• Disparities in Access to Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk African American Kidney Transplant Patients
  di: Shipra R. Bethi, et al.
  Pubblicazione: (2024)